NewAmsterdam Pharma

Esperion Therapeutics Inc

This company develops and commercialises oral cholesterol-lowering medicines for patients with hyperlipidaemia or at risk of cardiovascular disease.

Staten Biotechnology

This company develops monoclonal antibody therapies for patients with dyslipidaemia to reduce cardiovascular risk and lower triglyceride levels.

Shifa

This biopharmaceutical company develops oral small molecule drugs to treat cardiovascular disease and dyslipidemia for patients with high cholesterol.

Lexeo Therapeutics

This clinical-stage company develops gene therapies for patients with genetically defined cardiovascular diseases and Alzheimer's disease.

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.

Rocket Pharma

This company develops gene therapies for patients with rare and devastating genetic cardiovascular and haematological diseases.

Omthera Pharmaceuticals

This biopharmaceutical company develops omega-3 fatty acid therapies to treat patients with dyslipidemia and high triglyceride levels.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.